What does DR. KETELS VEERLE - NEUROLOOG do?

DR. KETELS VEERLE - NEUROLOOG is a specialist medical practice in Lokeren. Private Limited, started on 4 June 2015, 1 establishment.

What is the address of DR. KETELS VEERLE - NEUROLOOG?

The registered office of DR. KETELS VEERLE - NEUROLOOG is located at Windhaarstraat 19, 9160 Lokeren.

Is DR. KETELS VEERLE - NEUROLOOG still active?

Yes. According to the CBE (30 September 2026) DR. KETELS VEERLE - NEUROLOOG is active, legal situation “Normale toestand”, started on 4 June 2015.

Is DR. KETELS VEERLE - NEUROLOOG registered on Peppol?

Yes, DR. KETELS VEERLE - NEUROLOOG is registered on the Peppol network with ID 0208:0631756347.

What is the enterprise number of DR. KETELS VEERLE - NEUROLOOG?

The enterprise number of DR. KETELS VEERLE - NEUROLOOG is BE0631756347.

When was DR. KETELS VEERLE - NEUROLOOG founded?

DR. KETELS VEERLE - NEUROLOOG was founded on 4 June 2015.

Who are the directors of DR. KETELS VEERLE - NEUROLOOG?

According to the 2025 annual accounts, the directors of DR. KETELS VEERLE - NEUROLOOG are: Veerle Ketels.

Is DR. KETELS VEERLE - NEUROLOOG a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 June 2015; 6 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. KETELS VEERLE - NEUROLOOG make in 2025?

DR. KETELS VEERLE - NEUROLOOG recorded a loss after taxes of € 73,399 in financial year 2025.

What is the revenue of DR. KETELS VEERLE - NEUROLOOG?

As a small company, DR. KETELS VEERLE - NEUROLOOG is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -51,265.

DR. KETELS VEERLE - NEUROLOOG (Private Limited) - Lokeren

Dossier DR. KETELS VEERLE - NEUROLOOG, printed on 30 September 2026 from databakkes.be/en/0631756347/dr-ketels-veerle-neuroloog. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. KETELS VEERLE - NEUROLOOG from Lokeren, company number BE0631756347, closed financial year 2025 with a result of € -73,399 after tax. For that financial year DR. KETELS VEERLE - NEUROLOOG recorded a gross margin of € -51,265 and equity of € 267,821. Compared with financial year 2024, the result moved from € 102,344 to € -73,399. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.

What it is worth Healthy

€ 267,821

▼ 43% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -73,399

▼ still € 102,344 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 46,154

▼ 43% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 249,221.

People and assets in 2025

Vehicles and equipment

€ 87,577

▼ 21% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 21,683

▲ € 21,653 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 751

▼ 97% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 165,273 Gross margin 2022: € 165,273 First fiscal year in the series	€ 43,354 Gross margin 2023: € 43,354 ▼ 74% vs 2022 (€ 165,273) Unfavourable step	€ 169,103 Gross margin 2024: € 169,103 ▲ 290% vs 2023 (€ 43,354) Favourable step	€ -51,265 Gross margin 2025: € -51,265 ▼ € 220,368 vs 2024 (€ 169,103) Unfavourable step	▼ € 220,368
Profit after taxes	€ 96,305 Profit after taxes 2022: € 96,305 First fiscal year in the series	€ 22,357 Profit after taxes 2023: € 22,357 ▼ 77% vs 2022 (€ 96,305) Unfavourable step	€ 102,344 Profit after taxes 2024: € 102,344 ▲ € 79,987 vs 2023 (€ 22,357) Favourable step	€ -73,399 Profit after taxes 2025: € -73,399 ▼ € 175,743 vs 2024 (€ 102,344) Unfavourable step	▼ € 175,743
Equity	€ 479,600 Equity 2022: € 479,600 First fiscal year in the series	€ 501,957 Equity 2023: € 501,957 ▲ 5% vs 2022 (€ 479,600) Favourable step	€ 472,362 Equity 2024: € 472,362 ▼ 6% vs 2023 (€ 501,957) Unfavourable step	€ 267,821 Equity 2025: € 267,821 ▼ 43% vs 2024 (€ 472,362) Unfavourable step	▼ 43%
Total debts	€ 14,243 Total debts 2022: € 14,243 First fiscal year in the series	€ 6,864 Total debts 2023: € 6,864 ▼ 52% vs 2022 (€ 14,243) Favourable step	€ 25,929 Total debts 2024: € 25,929 ▲ 278% vs 2023 (€ 6,864) Unfavourable step	€ 92,609 Total debts 2025: € 92,609 ▲ 257% vs 2024 (€ 25,929) Unfavourable step	▲ 257%
Cash	€ 430,457 Cash 2022: € 430,457 First fiscal year in the series	€ 92,908 Cash 2023: € 92,908 ▼ 78% vs 2022 (€ 430,457) Unfavourable step	€ 80,957 Cash 2024: € 80,957 ▼ 13% vs 2023 (€ 92,908) Unfavourable step	€ 46,154 Cash 2025: € 46,154 ▼ 43% vs 2024 (€ 80,957) Unfavourable step	▼ 43%
Retained profit	€ 461,000 Retained profit 2022: € 461,000 First fiscal year in the series	€ 483,357 Retained profit 2023: € 483,357 ▲ 5% vs 2022 (€ 461,000) Favourable step	€ 453,762 Retained profit 2024: € 453,762 ▼ 6% vs 2023 (€ 483,357) Unfavourable step	€ 249,221 Retained profit 2025: € 249,221 ▼ 45% vs 2024 (€ 453,762) Unfavourable step	▼ 45%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 131,939 Dividend 2024: € 131,939 Unchanged (€ 0) Unchanged	€ 131,143 Dividend 2025: € 131,143 ▼ 1% vs 2024 (€ 131,939) Unchanged	▼ 1%
Balance sheet total	€ 493,843 Balance sheet total 2022: € 493,843 First fiscal year in the series	€ 508,821 Balance sheet total 2023: € 508,821 ▲ 3% vs 2022 (€ 493,843) Unchanged	€ 498,291 Balance sheet total 2024: € 498,291 ▼ 2% vs 2023 (€ 508,821) Unchanged	€ 360,430 Balance sheet total 2025: € 360,430 ▼ 28% vs 2024 (€ 498,291) Unchanged	▼ 28%

Key figures of DR. KETELS VEERLE - NEUROLOOG, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. KETELS VEERLE - NEUROLOOG?

What happened at DR. KETELS VEERLE - NEUROLOOG in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 27, 2026 New annual accounts for financial year 2025: loss of € 73,399 (▼ € 175,743 vs 2024). filed late Source: NBB ↗
Jun 4, 2015 Start of the company according to the CBE. KBO
Jun 3, 2015 New establishment in Lokeren. KBO
2015 Veerle Ketels became a director. NBB

In short

From € 96,305 profit in 2022 to € 73,399 loss in 2025.

Paid € 101,324 in corporate taxes since 2022.

Best year ever: 2024, with € 102,344 profit.

Paid out € 263,082 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. KETELS VEERLE - NEUROLOOG? We notify you, reason included.

Follow DR. KETELS VEERLE - NEUROLOOG

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Veerle Ketels

DR. KETELS VEERLE - NEUROLOOG

Behind DR. KETELS VEERLE - NEUROLOOG is Veerle Ketels.

See the full network in the app

Directors

According to the 2025 annual accounts

Veerle Ketels

Director

since 2015

Establishments

Establishment units

Physical locations of this company

Registered office

Windhaarstraat 19

9160 Lokeren

2.242.615.056

Lepelstraat 2

9160 Lokeren

Active since 3 June 2015

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0631.756.347
VAT number: BE 0631.756.347
Registered office: Windhaarstraat 19, 9160 Lokeren
Names & denominations: DR. KETELS VEERLE - NEUROLOOG
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 4 June 2015
Peppol: Active · Active since 3 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗